Timothy Scannell

Track

Insider profile

Currently holds positions in Insulet Corp and Stryker Corp

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 19% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Insulet Corp Jan. 1, 2019 -
President, Chief Operating Officer Stryker Corp Aug. 1, 2018 -
Independent Director Insulet Corp Aug. 12, 2014 - Jan. 1, 2019
Group President - MedSurg and Neurotechnology Stryker Corp Jan. 1, 2013 - Aug. 1, 2018
Group President - MedSurg and Spine Stryker Corp Sept. 1, 2009 - Jan. 1, 2013
Timothy Scannell's trades of Novocure Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02
US Novocure Ltd (NVCR)
S Sale
98,773 +45.6%
494.34
US$2,030,211 		98,773 +45.6% 494.34 US$2,030,211
2025-06-04 2025-06-03
US Novocure Ltd (NVCR)
S Sale
38,720 -4.2%
140.59
US$3,234,625 		38,720 -4.2% 140.59 US$3,234,625
2024-09-11 2024-09-10
US Insulet Corp (PODD)
S Sale
73,565 -3.1%
285.29
US$1,860,730 		73,565 -3.1% 285.29 US$1,860,730
2024-09-10 2024-09-10
US Insulet Corp (PODD)
PrS Proposed sale
5,000
225.84
US$1,129,210 		5,000 225.84 US$1,129,210
2024-06-11 2024-06-10
US Insulet Corp (PODD)
S Sale
7,000 -16.4%
190.51
US$1,333,570 		7,000 -16.4% 190.51 US$1,333,570
2024-06-10 2024-06-10
US Insulet Corp (PODD)
PrS Proposed sale
7,000
190.51
US$1,333,569 		7,000 190.51 US$1,333,569
2024-06-06 2024-06-04
US Novocure Ltd (NVCR)
S Sale
964 -24.5%
23.89
US$23,027 		964 -24.5% 23.89 US$23,027
2024-05-29 2024-05-28
US Insulet Corp (PODD)
S Sale
3,300 -7.2%
180.90
US$596,970 		3,300 -7.2% 180.90 US$596,970
2024-05-28 2024-05-28
US Insulet Corp (PODD)
PrS Proposed sale
3,300
180.90
US$596,981 		3,300 180.90 US$596,981
2020-11-24 2020-11-23
US Stryker Corp (SYK)
S Sale
5,000 -2.3%
232.61
US$1,163,038 		5,000 -2.3% 232.61 US$1,163,038
2019-10-17 2019-10-16
US Stryker Corp (SYK)
S Sale
4,666 -2.9%
214.50
US$1,000,839 		4,666 -2.9% 214.50 US$1,000,839
2019-09-18 2019-09-17
US Stryker Corp (SYK)
S Sale
4,666 -2.9%
218.51
US$1,019,583 		4,666 -2.9% 218.51 US$1,019,583
2019-07-17 2019-07-16
US Stryker Corp (SYK)
S Sale
4,666 -3.0%
205.88
US$960,656 		4,666 -3.0% 205.88 US$960,656
2019-06-19 2019-06-18
US Stryker Corp (SYK)
S Sale
4,666 -3.0%
197.68
US$922,387 		4,666 -3.0% 197.68 US$922,387
2019-05-17 2019-05-16
US Stryker Corp (SYK)
S Sale
4,666 -3.0%
186.71
US$871,210 		4,666 -3.0% 186.71 US$871,210
2019-04-17 2019-04-16
US Stryker Corp (SYK)
PlS Planned sale
4,666 -3.0%
192.40
US$897,727 		4,666 -3.0% 192.40 US$897,727
2019-03-19 2019-03-18
US Stryker Corp (SYK)
PlS Planned sale
4,666 -3.4%
193.28
US$901,829 		4,666 -3.4% 193.28 US$901,829
2019-02-20 2019-02-19
US Stryker Corp (SYK)
S Sale
4,666 -3.4%
186.25
US$869,040 		4,666 -3.4% 186.25 US$869,040
2019-01-17 2019-01-16
US Stryker Corp (SYK)
S Sale
5,282 -3.9%
163.50
US$863,590 		5,282 -3.9% 163.50 US$863,590